In addition to IDH1/2, 1p/19q, MGMT, hTERT, TP53, PTEN, EGFR, and ATRX, which were investigated here, we plan to evaluate other genetic markers related to glioma characteristics and prognosis, as well as those recognized as therapeutic and immune targets. This evidence concerns the gene EGFR and glioma.